Atossa Genetics Inc (ATOS) Stock Price

0.7798 ▲ +0.0088 (+1.14%)
Open: 0.775 Vol: 628.55K Day's range: 0.7718 - 0.8073 Nov 26, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ATOS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.79▼ 0.79▼ 0.79▼ 0.77▲ 0.81▼
MA10 0.79▼ 0.79▼ 0.78▲ 0.78▲ 0.89▼
MA20 0.79▼ 0.78▲ 0.77▲ 0.81▼ 0.85▼
MA50 0.78▲ 0.77▲ 0.78▲ 0.89▼ 0.83▼
MA100 0.78▲ 0.78▲ 0.80▼ 0.86▼ 1.07▼
MA200 0.78▲ 0.81▼ 0.86▼ 0.82▼ 0.98▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ 0.002▲ 0.004▲ -0.001▼ -0.011▼
RSI 50.883▲ 52.683▲ 54.489▲ 39.891▼ 43.656▼
STOCH 21.249     74.959     86.415▲ 17.636▼ 14.432▼
WILL %R -64.706     -41.463     -35.484     -73.259     -93.392▼
CCI -80.183     20.865     69.642     -31.063     -73.355    
Latest Filters Detected On ATOS
CDL $ATOS Shooting Star Candlestick Pattern Detected Set Alert
CDL $ATOS Doji Candlestick Pattern Detected Set Alert
Atossa Genetics Inc News
Atossa Therapeutics Announces Acceptance of Four Abstracts Highlighting (Z)-Endoxifen Research for Presentation at the 2025 San Antonio Breast Cancer Symposium
Thursday, November 06, 2025 05:01 AM
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, announces that four abstracts featuring ...
Atossa Therapeutics to Present at the Maxim Growth Summit 2025
Tuesday, October 14, 2025 10:00 PM
SEATTLE, Oct. 15, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing new approaches in breast cancer ...
Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness
Tuesday, October 14, 2025 06:00 AM
25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial operations with (Z)-endoxifen SEATTLE, ...
ATOS historical stock data
date open high low close volume
26/11/25 0.775 0.8073 0.7718 0.7798 628,554
25/11/25 0.7571 0.7778 0.7516 0.771 237,111
24/11/25 0.80 0.8198 0.7484 0.7516 792,777
21/11/25 0.7533 0.7832 0.7437 0.7802 595,328
20/11/25 0.7637 0.7959 0.752 0.752 496,951
19/11/25 0.79 0.7999 0.7583 0.7636 453,423
18/11/25 0.7748 0.82 0.7721 0.79 427,868
17/11/25 0.81 0.85 0.7701 0.785 761,653
14/11/25 0.79 0.8247 0.779 0.80 482,976
13/11/25 0.7974 0.8256 0.77 0.8027 781,880
Quote Details
52wk Low:0.553
52wk High:1.31
Vol:628.55K
Avg Vol(3m):17.5M
1Y Chng:-32.19%
1M Chng:-24.29%
Add to Watch List
More Information
Index US Composite
Market Cap. 100.73M